Treatment of recalcitrant psoriasis and psoriatic arthritis can be challenging, with treatment options limited by drug intolerance or poor efficacy. High-dose intravenous immunoglobulin (hdIVIg) has been used successfully in Kawasaki's disease and idiopathic thrombocytopenic purpura, where it has be
β¦ LIBER β¦
Caffey disease responding to high-dose immunoglobulin
β Scribed by M. Berthier; D. Bonneau; J. L. Huret
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 414 KB
- Volume
- 147
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Psoriasis: response to high-dose intrave
β
V. Gurmin; R. Mediwake; M. Fernando; S. Whittaker; M.H.A. Rustin; H.L.C. Beynon
π
Article
π
2002
π
John Wiley and Sons
π
English
β 59 KB
Acquired von willebrand disease: Correct
β
Dr. A. Delmer; M. H. Horellou; J. M. BrΓ©chot; J. Prudent; F. Potevin; C. Lecrubi
π
Article
π
1992
π
John Wiley and Sons
π
English
β 165 KB
π 1 views
High-dose intravenous immunoglobulins (ivlG) were used in a 57-year-old patient with acquired von Willebrand disease in order to correct a hemostatic defect before pneumonectomy for lung carcinoma. IvlG induced a rapid and complete correction of factor Vlll (F VIII) and von Willebrand factor (vWF) a
Severe hemolytic anemia following high-d
β
Nakagawa, Masao; Watanabe, Noriko; Okuno, Masahiko; Kondo, Masanori; Okagawa, Hi
π
Article
π
2000
π
John Wiley and Sons
π
English
β 196 KB
π 2 views
Experience with monthly, high-dose, intr
β
Sevil Kamali; Ayse Cefle; Mehmet Sayarlioglu; Ahmet Gul; Murat Inanc; Lale Ocal;
π
Article
π
2004
π
Springer
π
English
β 182 KB
Intravenous Administration of Radiolabel
β
Huib M. Vriesendorp; Francine J. Vriesendorp
π
Article
π
2003
π
John Wiley and Sons
β 52 KB
Neutropenias following allogeneic bone m
β
Khouri, Issa F.; Ippoliti, Cindy; Gajewski, James; Przepiorka, Donna; Champlin,
π
Article
π
1996
π
John Wiley and Sons
π
English
β 249 KB
π 2 views
Cytopenias following bone marrow transplantation may be severe and life-threatening. These have been described post-allogeneic Klumpp, 1991 : Bone Marrow Transplant 8:159-171. or post-autologous bone marrow transplants